Hypertension is used to describe an elevation in blood pressure. Blood pressure does tend to fluctuate depending on the time of day and exertion levels for example, however, when we talk about hypertension we are referring to a chronically raised blood pressure. Hypertension is typically asymptomatic, but it is an important risk factor for cardiovascular and cerebrovascular diseases.
🏘️ Epidemiology
According to the WHO, 1.13 billion people have hypertension globally. Most of which live in low/middle-income counties. In England it has a prevalence of 31% in men and 26% in women.
It is the 2nd biggest global risk factor for disease (after poor diet) and it is the single most important risk factor for the development of cardiovascular disease, increasing the risk of CAD, stroke, HF.
It also is a major risk factor for PAD, CKD, and vascular dementia as well as numerous other diseases throughout the body.
🏃 Physiology and pathophysiology
Blood pressure is an indicator of CVS function. It measures the pressure within our cardiovascular system throughout the cardiac cycle.
The formula for blood pressure is:
- Cardiac output - the more blood that is being pumped through our vessels, the higher the pressure. It is dependant on the heart rate as well as the stroke volume.
- Peripheral resistance - if the blood vessels are more constricted there is higher pressure through them.
Our blood pressure is measured with 2 components, a systolic pressure and diastolic pressure. A normal blood pressure lies between 120/80 - 135/85.
NICE classifies hypertension as a blood pressure of 140/90 (in clinic) or 135/85 (with ambulatory or home readings).
The cause of hypertension can be divided into primary (essential) causes and secondary causes
- Essential hypertension - also known as primary or idiopathic hypertension. It makes up 95% of hypertensive cases. Its aetiology is multi factorial and not entirely understood but can be due to sympathetic hyperactivity, endothelial dysfunction, inappropriate RAAS activity, excessive sodium intake.
- Secondary hypertension - due to ROPE.
- R - Renal disease - most common secondary cause.
- O - Obesity/other
- P - Pregnancy/pre-eclampsia
- E - Endocrine disorders
Renal disease | Endocrine disorders | Other causes |
Glomerulonephritis | Primary hyperaldosteronism (Conn’s syndrome) | Glucocorticoids |
Chronic pyelonephritis | Phaeochromocytoma | NSAIDs |
Adult PCKD | Cushing’s syndrome | Coarctation of the aorta |
Renal artery stenosis | Liddle’s syndrome | Combined oral contraceptive |
CKD | Congenital adrenal hyperplasia | |
Acromegaly |
⚠️ Risk factors
- >65 years of age
- Alcohol intake
- Sedentary lifestyle
- Family history
- Obesity
- Diabetes
- Black ancestry
- Obstructive sleep apnoea
😷 Presentation
⭐️ Hypertension is asymptomatic, unless the blood pressure reaches extremely high pressures in hypertensive crisis (such as >200/120mmHg for example).
Typically, it is identified when checking someone’s blood pressure. White-coat hypertension is a concern as a blood pressure in clinic is sometimes higher than when taken at home (it is defined as a blood pressure of 20/10mmHg more than with ambulatory or home readings. This has changed the manner in which hypertension has been diagnosed as we now typically use ambulatory monitors.
The converse may also be true, where patients have masked hypertension. This occurs when they have a normal BP in clinic but higher BP when taken outside of clinic with ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM).
In longstanding hypertension we may see:
- Visual disturbances - due to retinopathy with longstanding hypertension.
- Chest pain - suggestive of CAD.
- Headaches - if it is a hypertensive crisis.
- Sensory or motor deficits - if it presents due to a complication with cerebrovascular disease.
💯 Criteria and staging
The JNC-7 definitions from 2004 for hypertension have been adopted in 2014, and these have set the pharmacological treatment thresholds for hypertension subsequently:
Normal blood pressure | <120/80mmHg |
Pre-hypertension | 120-139/80-89mmHg |
Stage 1 hypertension | >140/90mmHg and subsequent ABPM or HBPM average of >135/85 |
Stage 2 hypertension | >160/100mmHg and subsequent ABPM or HBPM average of >150/95mmHg |
Stage 3/severe hypertension | Systolic of >180mmHg or higher or diastolic of >120mmHg or higher |
🔍 Investigations
- 🥇 When considering a diagnosis we should measure blood pressure in both arms.
- If the difference is >15mmHg, then repeat measurements. If it remains higher then measure the BP subsequently in the arm with the higher reading.
- If >140/90mmHg → take second measurement during the consultation and record the lower of the 2.
- If significantly different → take a third measurement.
- 🏆 If it remains >140/90 then offer ABPM to confirm the diagnosis. If ABPM is not possible then offer HBPM for confirmation.
- While waiting it is important to do investigations to look for end-organ damage (more on this below) and also to perform a formal risk assessment for CVD using the QRISK2 risk assessment.
ABPM requires 2 measurements per hour during the usual waking hours of the patient. The average value of at least 14 measurements taken are used to confirm the diagnosis.
HBPM requires 4-7 days of recording twice daily (morning and evening). Each recording should be done twice, at least 1 minute apart with the individual seated. We should discard the measurement on the first day and use the average for all the remaining measurements to confirm the diagnosis.
Other investigations to assess for end-organ damage include:
- U&Es - assessing for renal disease as a cause or consequence of hypertension.
- HbA1c - to look for co-existing DM (another important risk factor for CVD).
- Lipids - to look for co-existing hyperlipidaemia.
- ECG - to assess for evidence of left ventricular hypertrophy or evidence of an old infarction.
- Urine dipstick and ACR - once again looking for evidence of DM or renal disease.
- Fundus examination - to assess for hypertensive retinopathy.
🧰 Management
First, let’s discuss who should receive treatment in stage 1 hypertension and stage 2 hypertension. Then let’s look at the treatment algorithm.
We should treat it if <80 years old and they have any of the following:
- End-organ damage
- CVD
- Renal disease
- Diabetes
- 10-year QRISK2 score of >10%
For patients >80 years old the threshold for treatment goes up to 150/90.
Drug treatment should be offered, regardless of their age.
The treatment involves a 4 step pathway outlined by NICE:
Step 1
<55 years or T2DM
- A - either:
- ARB (angiotensin receptor blocker)
- ACEI (ACE inhibitor)
OR
ARBs are used when ACEIs are not tolerated. We will discuss some of the adverse effects of these drugs below.
>55 years + no T2DM or Afro-Carrobean + no T2DM
- C - CCB (calcium channel blocker)
Step 2
- If already on an ACEI/ARB → add CCB or thiazide diuretic (A+C or A+D)
- If already on a CCB → add ACEI or ARB or thiazide diuretic (C+A or C+A or C+D)
Step 3
Add a third drug to complete the A + C + D.
Step 4
This is referred to as resistant hypertension and requires the addition of a 4th drug or specialist input. Before giving this we need to confirm the BP, assess for postural hypotension, and discuss the adherence of medication. Then we can give the 4th medication which is dependent on potassium levels
- K+ <4.5mmol/L → add low-dose spirinolactone. Monitoring of potassium is needed after starting spirinolactone.
- K+ >4.5mmol/L → add alpha-blocker or beta-blocker.
If the patient still fails to have controlled BP after all 4 steps then specialist review is required.
Other management factors include:
- Risk factor modification - low-salt diet (DASH), reducing caffeine intake, restricting alcohol intake, smoking cessation, exercise etc.
- Complication monitoring
Dear future Sarmad,
Please add in the MOAs and adverse effects of the drugs within these classes when you have the time.
Kind regards,
Sarmad (18/01/2023)
Hypokalaemia in hypertension
Hypokalaemia is associated with hypertension and it is valuable to be aware of which are associated with hypertension and what are the causes without hypertension.
Hypokalaemia WITH hypertension | Hypokalaemia WITHOUT hypertension |
Cushing’s syndrome | Diuretics |
Conn’s syndrome (primary hyperaldosteronism) | GI losses such as diarrhoea and vomiting |
Liddle’s syndrome | Renal tubular acidosis |
11-ß hydroxylase deficiency | Barter’s syndrome |
Liquorice excess and carbenoxolone (an anti-ulcer drug) can potentially lead to hypokalaemia with hypertension. | Gitelman syndrome |